NCT06246071View on ClinicalTrials.gov

A Study of TYK-00540 in Adult Patients With Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 5, 2026

Study Completion Date

December 5, 2026

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG

TYK-00540

TYK-00540 PO, BID

Trial Locations (1)

Unknown

RECRUITING

Anhui Provincial Hospital, Hefei

All Listed Sponsors

lead

TYK Medicines, Inc

INDUSTRY